Company / EPS (Diluted)
Phio Pharmaceuticals Corp. EPS (Diluted) History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$19.33
FY2020
5-year range
-$57.46 / -$2.10
FY2016-FY2020
Trend
+66.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 7 years, ranging from $-57.46 in FY2019 to $-0.28 in FY2012.
Based on SEC 10-K filings.
-19.33 in FY2020.
Declined from $-5.52 to $-19.33 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, eps (diluted) increased 66.4% year-over-year.
- Peak eps (diluted) was recorded in FY2012.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$19.33 | +66.4% |
| FY2019 | -$57.46 | -940.9% |
| FY2018 | -$5.52 | +66.4% |
| FY2017 | -$16.41 | -681.4% |
| FY2016 | -$2.10 | +62.6% |
| FY2013 | -$5.62 | -1907.1% |
| FY2012 | -$0.28 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026